Upstream Bio (UPB) Payables (2023 - 2025)
Historic Payables for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $4.0 million.
- Upstream Bio's Payables fell 1933.05% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 1933.05%. This contributed to the annual value of $4.0 million for FY2024, which is 10306.53% up from last year.
- Latest data reveals that Upstream Bio reported Payables of $4.0 million as of Q3 2025, which was down 1933.05% from $2.6 million recorded in Q2 2025.
- Upstream Bio's Payables' 5-year high stood at $4.9 million during Q3 2024, with a 5-year trough of $2.0 million in Q4 2023.
- For the 3-year period, Upstream Bio's Payables averaged around $3.7 million, with its median value being $4.0 million (2024).
- In the last 5 years, Upstream Bio's Payables surged by 10306.53% in 2024 and then tumbled by 1933.05% in 2025.
- Over the past 3 years, Upstream Bio's Payables (Quarter) stood at $2.0 million in 2023, then surged by 103.07% to $4.0 million in 2024, then dropped by 2.2% to $4.0 million in 2025.
- Its last three reported values are $4.0 million in Q3 2025, $2.6 million for Q2 2025, and $4.7 million during Q1 2025.